Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Schmidt O, Nehls N, Prexler C, von Heyking K, Groll T, Pardon K, Garcia HD, Hensel T, Gürgen D, Henssen AG, Eggert A, Steiger K, Burdach S, Richter GHS. Schmidt O, et al. Among authors: prexler c. J Exp Clin Cancer Res. 2021 Oct 15;40(1):322. doi: 10.1186/s13046-021-02125-z. J Exp Clin Cancer Res. 2021. PMID: 34654445 Free PMC article.
Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Schmidt O, Nehls N, Prexler C, von Heyking K, Groll T, Pardon K, Garcia HD, Hensel T, Gürgen D, Henssen AG, Eggert A, Steiger K, Burdach S, Richter GHS. Schmidt O, et al. Among authors: prexler c. J Exp Clin Cancer Res. 2022 Jan 3;41(1):7. doi: 10.1186/s13046-021-02174-4. J Exp Clin Cancer Res. 2022. PMID: 34980229 Free PMC article. No abstract available.
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma.
Richter GHS, Hensel T, Schmidt O, Saratov V, von Heyking K, Becker-Dettling F, Prexler C, Yen HY, Steiger K, Fulda S, Dirksen U, Weichert W, Wang S, Burdach S, Schäfer BW. Richter GHS, et al. Among authors: prexler c. Cancers (Basel). 2020 Jan 28;12(2):304. doi: 10.3390/cancers12020304. Cancers (Basel). 2020. PMID: 32012890 Free PMC article.
MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.
Sipol A, Hameister E, Xue B, Hofstetter J, Barenboim M, Öllinger R, Jain G, Prexler C, Rubio RA, Baldauf MC, Franchina DG, Petry A, Schmäh J, Thiel U, Görlach A, Cario G, Brenner D, Richter GHS, Grünewald TGP, Rad R, Wolf E, Ruland J, Sorensen PH, Burdach SEG. Sipol A, et al. Among authors: prexler c. Blood. 2022 Feb 24;139(8):1184-1197. doi: 10.1182/blood.2020007932. Blood. 2022. PMID: 33908607 Free PMC article.
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy.
Weidenbusch B, Richter GHS, Kesper MS, Guggemoos M, Gall K, Prexler C, Kazantsev I, Sipol A, Lindner L, Nathrath M, Witt O, Specht K, Beitinger F, Knebel C, Hosie S, von Eisenhardt-Rothe R, Weichert W, Luettichau IT, Burdach S. Weidenbusch B, et al. Among authors: prexler c. Oncotarget. 2018 Apr 17;9(29):20747-20760. doi: 10.18632/oncotarget.25087. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755686 Free PMC article.
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.
Schober SJ, Hallmen E, Reßle F, Gassmann H, Prexler C, Wawer A, von Luettichau I, Ladenstein R, Kazanowska B, Ljungman G, Niggli F, Lohi O, Hauer J, Gruhn B, Klingebiel T, Bader P, Burdach S, Lang P, Sparber-Sauer M, Koscielniak E, Thiel U. Schober SJ, et al. Among authors: prexler c. Front Oncol. 2022 May 10;12:878367. doi: 10.3389/fonc.2022.878367. eCollection 2022. Front Oncol. 2022. PMID: 35619911 Free PMC article.
Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.
Prexler C, Knape MS, Erlewein-Schweizer J, Roll W, Specht K, Woertler K, Weichert W, von Luettichau I, Rossig C, Hauer J, Richter GHS, Weber W, Burdach S. Prexler C, et al. Cancers (Basel). 2022 Dec 5;14(23):5999. doi: 10.3390/cancers14235999. Cancers (Basel). 2022. PMID: 36497479 Free PMC article.